Phase I/II study of etanercept and rituximab in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Etanercept; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 08 Feb 2017 Biomarkers information updated
- 04 Aug 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 04 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.